ROCKET PHARMACEUTICALS, INC. short interest in 2019
In 2019, ROCKET PHARMACEUTICALS, INC.'s disclosed short interest ran from 14.13% of shares outstanding on 15 Oct 2019 to 14.47% on 31 Dec 2019, a change of +0.34 percentage points. The year's high was 14.64% on 29 Nov 2019 and its low 14.13% on 15 Oct 2019, averaging 14.38% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.28 days on 15 Nov 2019. Full history: ROCKET PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 14.13% (15 Oct 2019)
- End of year
- 14.47% (31 Dec 2019)
- Change
- +0.34 pp
- High
- 14.64% (29 Nov 2019)
- Low
- 14.13% (15 Oct 2019)
- Average
- 14.38%
- Highest days to cover
- 37.28 (15 Nov 2019)
- SEC filings marked
- 4
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 14.13% | 30.93 | 10-K filed, 10-Q filed, 10-Q filed |
| 31 Oct 2019 | 14.33% | 35.34 | |
| 15 Nov 2019 | 14.16% | 37.28 | 10-Q filed |
| 29 Nov 2019 | 14.64% | 30.95 | |
| 13 Dec 2019 | 14.54% | 9.38 | |
| 31 Dec 2019 | 14.47% | 20.00 |
See also: ROCKET PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.